All In MedTech

Device Trial Radar · NCT06189365

Amplatzer Amulet China Post Market Study (PMS)

Last checked: Nov 19, 2026Latest source record: Aug 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

50

Actual

Start

Jan 30, 2024

Primary completion

Dec 5, 2025

Study completion Dec 5, 2025

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
First posted
Jan 3, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to prospectively evaluate the safety and effectiveness of the Amplatzer Amulet LAA occluder in a Chinese patient population indicated for use of this device.

Conditions

  • Non-Valvular Atrial Fibrillation

Interventions

  • Left Atrial Appendage (LAA) closure procedure with Amplatzer Amulet LAA occluderDevice

    Subject will receive the Left Atrial Appendage (LAA) closure procedure with Amplatzer Amulet LAA occluder.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Short-Term Safety Endpoint: Occurrence of Major Adverse EventsTime frame: 7 days
  2. Primary Long-Term Safety Endpoint: Occurrence of Device Embolization, Device Erosion, Significant Device Interference With Surrounding Structure, Device Thrombus, Device Fracture, Device Related Infections, Device Breakage, or Device Related AllergyTime frame: 2 years
  3. Primary Effectiveness Endpoint: Composite of Ischemic Stroke or Systemic EmbolismTime frame: 2 years

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • University of Hong Kong-Shenzhen Hospital

    Shenzhen, Guangdong, China

  • Wuhan Asia Heart Hospital

    Wuhan, Hubei, China

  • The Third Xiangya Hospital of Central South University

    Changsha, Hunan, China

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.